Influx Healthtech IPO Subscription Status
Influx Healthtech IPO received bids for 81,75,38,400 shares against 40,58,400 offered, an overall subscription of 201.44x at the close of bidding (20 Jun 2025). NII leads at 481.47x.
Last updated · day 3 figures
- Retail
- 117.70x
- NII
- 481.47x
- QIB
- 137.87x
- Total
- 201.44x
Where the demand is
Influx Healthtech IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 11,59,200 | 15,98,18,400 | ₹1,534.26 Cr | 137.87x |
| NII | 8,70,000 | 41,88,78,000 | ₹4,021.23 Cr | 481.47x |
| Retail | 20,29,200 | 23,88,42,000 | ₹2,292.88 Cr | 117.70x |
| Total | 40,58,400 | 81,75,38,400 | ₹7,848.37 Cr | 201.44x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Influx Healthtech IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 137.87x |
| NII | 481.47x |
| Retail | 117.70x |
| Total | 201.44x |
| Total added | 201.44x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Influx Healthtech IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Qualified Institutional Buyers | 11,59,200 | 28.56% |
| Non-Institutional Investors | 8,70,000 | 21.44% |
| Retail Individual Investors | 20,29,200 | 50.00% |
| Public issue | 40,58,400 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Influx Healthtech IPO subscription: FAQs
- What is the overall subscription of Influx Healthtech IPO?
- Influx Healthtech IPO is subscribed 201.44x overall as of day 3 (20 June 2025), with bids for 81,75,38,400 shares against 40,58,400 offered.
- What is the retail subscription of Influx Healthtech IPO?
- The retail portion is subscribed 117.70x as of day 3 (20 June 2025).
- What is the QIB and NII subscription of Influx Healthtech IPO?
- QIBs have subscribed 137.87x of their portion, and NIIs 481.47x as of day 3 (20 June 2025).
- How can I check Influx Healthtech IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Influx Healthtech IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 20 June 2025.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.